Vinod H. Srihari, MD

Professor of Psychiatry

DownloadHi-Res Photo

Appointments

Psychiatry

Primary

Additional Titles

Director, STEP Program

Fellow, Davenport College

Contact Info

vinod.srihari@yale.edu

Psychiatry

34 Park Street

New Haven, CT 06519

United States

About

Titles

Professor of Psychiatry

Director, STEP Program; Fellow, Davenport College

Biography

Dr. Srihari's scholarly focus is on improving the outcomes of early course schizophrenia spectrum disorders. His research interests span the translational continuum from studies of etiology and pathophysiology to interventions on clinical samples, to service level innovations. As Director of the STEP Program, he leads activities that connect this research to the missions of delivering a model service (the STEP Clinic), disseminating clinical best practices (via Learning Health Networks), education and workforce development and influencing policies that support the public health mission of early Intervention for schizophrenia spectrum disorders.

In his curricular work, he has led the development and implementation of an Evidence-Based Medicine (EBM) based approach to enabling psychiatrists in training to ask, access, appraise and apply the best available scientific evidence to their practice and to audit the health of the populations they are responsible for.

Dr. Srihari also consults with academic and non-academic healthcare systems that seek to initiate or refine early intervention services for recent onset or 'first-episode' psychosis.

Appointments

Psychiatry
Professor
Primary
Psychiatry

Education & Training

Fellow: Yale University School of Medicine (2005)

Resident: Yale University School of Medicine (2003)

MD: University of Rochester (1998)

BA: University of Rochester, Biology; Religion & Classics (1994)

- Download CV

Research

Overview

Medical Subject Headings (MeSH)

Biomarkers; Curriculum; Evidence-Based Medicine; Exosomes; Health Care Quality, Access, and Evaluation; Learning Health System; Mental Health Services; Mitochondrial Diseases; Oxidative Stress; Population Health; Psychotic Disorders; Public Health Informatics; Schizophrenia Spectrum and Other Psychotic Disorders

ORCID
0000-0003-1556-2332
STEP
View Lab Website

Research at a Glance

Yale Co-Authors

Frequent collaborators of Vinod H. Srihari's published research.

Publications

2024

TimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis
Mathis W, Ferrara M, Cahill J, Karmani S, Tayfur S, Srihari V. TimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis. PLOS ONE 2024, 19: e0302116. PMID: 39028697, PMCID: PMC11259254, DOI: 10.1371/journal.pone.0302116.
Peer-Reviewed Original Research
MeSH Keywords and Concepts
The Italian adaptation of the Mini‐SIPS, a tool for early detection of individuals at clinical high risk and first episode of psychosis: A preliminary study of implementation in an Italian FEP program
Ferrara M, Basaldella M, Vacca F, Woods S, Walsh B, Cannon T, Srihari V, Grassi L. The Italian adaptation of the Mini‐SIPS, a tool for early detection of individuals at clinical high risk and first episode of psychosis: A preliminary study of implementation in an Italian FEP program. Early Intervention In Psychiatry 2024 PMID: 38769052, DOI: 10.1111/eip.13548.
Peer-Reviewed Original Research
Concepts
Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration
Szmulewicz A, Martínez-Alés G, Logan R, Ferrara M, Kelly C, Fredrikson D, Gago J, Conderino S, Díaz-Caneja C, Galvañ J, Thorpe L, Srihari V, Yatham L, Sarpal D, Shinn A, Arango C, Öngür D, Hernán M, Collaboration O. Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration. American Journal Of Epidemiology 2024, 193: 1081-1087. PMID: 38576166, DOI: 10.1093/aje/kwae029.
Peer-Reviewed Original Research
Concepts
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker J, Bearden C, Billah T, Bouix S, Broome M, Buccilli K, Cadenhead K, Calkins M, Cannon T, Cecci G, Chen E, Cho K, Choi J, Clark S, Coleman M, Conus P, Corcoran C, Cornblatt B, Diaz-Caneja C, Dwyer D, Ebdrup B, Ellman L, Fusar-Poli P, Galindo L, Gaspar P, Gerber C, Glenthøj L, Glynn R, Harms M, Horton L, Kahn R, Kambeitz J, Kambeitz-Ilankovic L, Kane J, Kapur T, Keshavan M, Kim S, Koutsouleris N, Kubicki M, Kwon J, Langbein K, Lewandowski K, Light G, Mamah D, Marcy P, Mathalon D, McGorry P, Mittal V, Nordentoft M, Nunez A, Pasternak O, Pearlson G, Perez J, Perkins D, Powers A, Roalf D, Sabb F, Schiffman J, Shah J, Smesny S, Spark J, Stone W, Strauss G, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum I, Wolf D, Wolff P, Wood S, Yung A, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión R, Castro E, Cetin-Karayumak S, Chakravarty M, Cho Y, Cotter D, D’Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur R, Gur R, Hamilton H, Hoftman G, Jacobs G, Jarcho J, Ji J, Kohler C, Lalousis P, Lavoie S, Lepage M, Liebenthal E, Mervis J, Murty V, Nicholas S, Ning L, Penzel N, Poldrack R, Polosecki P, Pratt D, Rabin R, Eichi H, Rathi Y, Reichenberg A, Reinen J, Rogers J, Ruiz-Yu B, Scott I, Seitz-Holland J, Srihari V, Srivastava A, Thompson A, Turetsky B, Walsh B, Whitford T, Wigman J, Yao B, Yuen H, Ahmed U, Byun A, Chung Y, Do K, Hendricks L, Huynh K, Jeffries C, Lane E, Langholm C, Lin E, Mantua V, Santorelli G, Ruparel K, Zoupou E, Adasme T, Addamo L, Adery L, Ali M, Auther A, Aversa S, Baek S, Bates K, Bathery A, Bayer J, Beedham R, Bilgrami Z, Birch S, Bonoldi I, Borders O, Borgatti R, Brown L, Bruna A, Carrington H, Castillo-Passi R, Chen J, Cheng N, Ching A, Clifford C, Colton B, Contreras P, Corral S, Damiani S, Done M, Estradé A, Etuka B, Formica M, Furlan R, Geljic M, Germano C, Getachew R, Goncalves M, Haidar A, Hartmann J, Jo A, John O, Kerins S, Kerr M, Kesselring I, Kim H, Kim N, Kinney K, Krcmar M, Kotler E, Lafanechere M, Lee C, Llerena J, Markiewicz C, Matnejl P, Maturana A, Mavambu A, Mayol-Troncoso R, McDonnell A, McGowan A, McLaughlin D, McIlhenny R, McQueen B, Mebrahtu Y, Mensi M, Hui C, Suen Y, Wong S, Morrell N, Omar M, Partridge A, Phassouliotis C, Pichiecchio A, Politi P, Porter C, Provenzani U, Prunier N, Raj J, Ray S, Rayner V, Reyes M, Reynolds K, Rush S, Salinas C, Shetty J, Snowball C, Tod S, Turra-Fariña G, Valle D, Veale S, Whitson S, Wickham A, Youn S, Zamorano F, Zavaglia E, Zinberg J, Woods S, Shenton M. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin 2024, 50: 496-512. PMID: 38451304, PMCID: PMC11059785, DOI: 10.1093/schbul/sbae011.
Peer-Reviewed Original Research
Concepts
Correction: On the proportion of patients who experience a prodrome prior to psychosis onset: a systematic review and meta-analysis
Benrimoh D, Dlugunovych V, Wright A, Phalen P, Funaro M, Ferrara M, Powers A, Woods S, Guloksuz S, Yung A, Srihari V, Shah J. Correction: On the proportion of patients who experience a prodrome prior to psychosis onset: a systematic review and meta-analysis. Molecular Psychiatry 2024, 29: 1567-1567. PMID: 38351175, DOI: 10.1038/s41380-024-02481-0.
Peer-Reviewed Original Research
Concepts
On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis
Benrimoh D, Dlugunovych V, Wright A, Phalen P, Funaro M, Ferrara M, Powers A, Woods S, Guloksuz S, Yung A, Srihari V, Shah J. On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis. Molecular Psychiatry 2024, 29: 1361-1381. PMID: 38302562, DOI: 10.1038/s41380-024-02415-w.
Peer-Reviewed Original Research
Concepts
The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction
Hazan H, Ferrara M, Riley S, Li F, Zhou B, Kline E, Gibbs-Dean T, Karmani S, Tayfur S, Tek C, Keshavan M, Srihari V. The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction. Schizophrenia Research 2024, 264: 457-461. PMID: 38266513, PMCID: PMC10923115, DOI: 10.1016/j.schres.2024.01.022.
Peer-Reviewed Original Research
MeSH Keywords and Concepts
Role of Early Psychosis Detection in the Relationship Between Personal Income and Duration of Untreated Psychosis
Venkataraman S, Hazan H, Li F, Ferrara M, Harper A, Ma J, Shah J, Musket C, Levine N, Keshavan M, Srihari V. Role of Early Psychosis Detection in the Relationship Between Personal Income and Duration of Untreated Psychosis. Psychiatric Services 2024, 75: 427-433. PMID: 38204369, DOI: 10.1176/appi.ps.20230239.
Peer-Reviewed Original Research
Concepts
Schizophrenia, A Practical Primer
Keshavan M, Srihari V, Reddy R. Schizophrenia, A Practical Primer. 2024 DOI: 10.4324/9781315152806.
Peer-Reviewed Original Research

2023

The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service
Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

See All Publications

Clinical Trials

Current Trials

Teen Brain and Behavior Study
HIC ID1111009332RoleSub InvestigatorPrimary Completion Date12/21/2022
Recruiting ParticipantsGenderBothAge13 years - 17 years
Brain, Spinal Cord & Nervous SystemMental Health & Behavioral Research

Academic Achievements & Community Involvement

activity
Schizophrenia Research
Journal ServiceEditorial Board Member
Details
activity
Schizophrenia International Research Society (SIRS)
Professional OrganizationsMember
Details
activity
International Early Psychosis Association (IEPA)
Professional OrganizationsMember
Details
activity
Center for Evidence Based Medicine (CEBM), Oxford, U.K.
Professional OrganizationsMember
Details
activity
Early Psychosis Collaboration
Research
Details
02/01/2021 - PresentFerrara, Emilia-Romagna, Italy
Collaborators
Maria Ferrara, MD
Sinan Guloksuz, MD, PhD
Abstract/Synopsis
Building a European hub for collaborative clinical and research projects.

See All Achievements

Clinical Care

Overview

Psychiatry

Fact Sheets

Schizophrenia
Learn More on Yale Medicine

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

News & Links

Media

News

See All News

Related Links

Get In Touch

Contacts

vinod.srihari@yale.edu

Mailing Address

Psychiatry

34 Park Street

New Haven, CT 06519

United States

Locations

The STEP Program
Lab
Connecticut Mental Health Center
34 Park Street
New Haven, CT 06519
Get Directions

Appointments

Additional Titles

Contact Info

Titles

Biography

Appointments

Psychiatry

Other Departments & Organizations

Education & Training

Overview

Medical Subject Headings (MeSH)

ORCID

STEP

Research at a Glance

Yale Co-Authors

Fangyong Li, MS, MPH

Maria Ferrara, MD

John Krystal, MD

Sinan Guloksuz, MD, PhD

Cenk Tek, MD

Nicole Santamauro, MA

Publications

2024

2023

Clinical Trials

Current Trials

Schizophrenia Research

Schizophrenia International Research Society (SIRS)

International Early Psychosis Association (IEPA)

Center for Evidence Based Medicine (CEBM), Oxford, U.K.

Early Psychosis Collaboration

Overview

Clinical Specialties

Fact Sheets

Schizophrenia

Are You a Patient?

Media

Bus Advertisements for Early Detection campaign hosted by STEP Program

MindmapNotepad (1) (1)-2

News

Mindmap 2.0 on Connecticut Public Radio

Mindmap Launches Statewide Campaign to Support Early Detection of First-episode Psychosis in Teens and Young Adults

Riley Appointed Medical Director of STEP Clinic

STEP Learning Collaborative Trains First Cohort of Healthcare Leaders

Related Links

Contacts

Locations

The STEP Program